US Patent

US8778947 — Methods of administering pirfenidone therapy

Method of Use · Assigned to Intermune Inc · Expires 2033-08-30 · 7y remaining

Vulnerability score 62/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects improved methods of administering pirfenidone therapy when ciprofloxacin is also being administered.

USPTO Abstract

The disclosure relates to improved methods of administering pirfenidone therapy when ciprofloxacin is administered concomitantly.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

CodeDescriptionDrug
U-2044 —
U-2044 —
U-1613 —
U-2044 —

Patent Metadata

Patent number
US8778947
Jurisdiction
US
Classification
Method of Use
Expires
2033-08-30
Drug substance claim
No
Drug product claim
No
Assignee
Intermune Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.